100 likes | 119 Views
Access to Knowledge and Technologies, IP and Strategies for Green Technologies. WIPO ASIA-PACIFIC CONFERENCE ON NATIONAL IP STRATEGIES FOR DEVELOPMENT; Manila, October 2009. Outline. Context Role of Knowledge and Technology Strategies Access to “free use” technologies Incentives IP based
E N D
Access to Knowledge and Technologies, IP and Strategies for Green Technologies WIPO ASIA-PACIFIC CONFERENCE ON NATIONAL IP STRATEGIES FOR DEVELOPMENT; Manila, October 2009 ron marchant CB FRSA
Outline • Context • Role of Knowledge and Technology • Strategies • Access to “free use” technologies • Incentives • IP based • Other • Conclusions ron marchant CB FRSA
Context 1 ron marchant CB FRSA From IPCC
Context 2 ron marchant CB FRSA From IPCC
Context 3 ron marchant CB FRSA From IPCC
Mitigation Civil engineering Transport Energy supply and use Private Industry Waste management Agriculture Forestry Adaptation Water resources Coastal defences Agriculture Healthcare Biodiversity Role of Knowledge and Technology ron marchant CB FRSA Stern Report
Strategies 1 • Out of Patent • Non-patented • Better use of patent documentation • Better use of non-patent documentation • Technology transfer and sustainability • International Agencies • Government • Private Sector ron marchant CB FRSA
IP based incentives Advantages Devolves decision Protects investment Protects commercialisation Disadvantages Monopoly pricing Inhibit further innovation Imbalance Developed/developing Local SME/multinational; IP based incentives Lower fees Fast-track processing Expand patentability Encourage licensing Compulsory licensing Patent pooling Strategies 2 ron marchant CB FRSA
Non IP based Grants Publicly funded research Tax breaks Tax pollution Non IP based Prizes McCain’s auto prize The L prize Saltire prize Progressive Insurance Automotive prize Virgin Earth Challenge Grainger Challenge Strategies 3 ron marchant CB FRSA From Manging Intellectual Property
Conclusions • Avoid re-run of academic patent/anti-patent debate • Look at ideas from access to medicines debate • Prize + licence of right • Standards and pooling • Compulsory licensing ron marchant CB FRSA